Acceleron Pharma Inc Ret. on equity
What is the Ret. on equity of Acceleron Pharma Inc?
The Ret. on equity of Acceleron Pharma Inc is -32.39%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc
What does Acceleron Pharma Inc do?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Companies with ret. on equity similar to Acceleron Pharma Inc
- Integrated Research has Ret. on equity of -32.45%
- Dominus Acquisitions has Ret. on equity of -32.43%
- Norish Plc has Ret. on equity of -32.43%
- Voyager Digital has Ret. on equity of -32.42%
- Carbon Revolution has Ret. on equity of -32.42%
- Sabre Gold Mines has Ret. on equity of -32.41%
- Acceleron Pharma Inc has Ret. on equity of -32.39%
- Treviso Capital Corp has Ret. on equity of -32.36%
- UET United Electronic Technology AG has Ret. on equity of -32.36%
- Lincoln Minerals has Ret. on equity of -32.36%
- HemoGenyx Pharmaceuticals Plc has Ret. on equity of -32.35%
- Hemogenyx Pharmaceuticals Plc has Ret. on equity of -32.35%
- Sumo Logic has Ret. on equity of -32.32%